|
ZNF33A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.212200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.638300E-04 |
| Normal-vs-Stage2 |
1.222480E-02 |
| Normal-vs-Stage3 |
3.783300E-03 |
| Normal-vs-Stage4 |
1.683380E-01 |
| Stage1-vs-Stage2 |
6.089600E-01 |
| Stage1-vs-Stage3 |
7.002400E-01 |
| Stage1-vs-Stage4 |
8.976800E-01 |
| Stage2-vs-Stage3 |
8.659200E-01 |
| Stage2-vs-Stage4 |
6.457600E-01 |
| Stage3-vs-Stage4 |
7.029800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.153300E-04 |
| Normal-vs-AfricanAmerican |
8.679900E-03 |
| Normal-vs-Asian |
3.077200E-03 |
| Caucasian-vs-AfricanAmerican |
8.036400E-01 |
| Caucasian-vs-Asian |
9.796500E-02 |
| AfricanAmerican-vs-Asian |
8.932300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.030900E-04 |
| Normal-vs-Female |
1.088240E-01 |
| Male-vs-Female |
7.819800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.599500E-03 |
| Normal-vs-Extreme_Weight |
7.68190000000057E-05 |
| Normal-vs-Obese |
3.212200E-02 |
| Normal-vs-Extreme_Obese |
5.018100E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.660400E-01 |
| Normal_Weight-vs-Obese |
1.911030E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.070000E-01 |
| Extreme_Weight-vs-Obese |
4.510100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.889200E-01 |
| Obese-vs-Extreme_Obese |
1.898440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.031200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.722200E-02 |
| Normal-vs-Age(61-80Yrs) |
3.51650000000037E-05 |
| Normal-vs-Age(81-100Yrs) |
2.18659999999815E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.773400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.448000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.139400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.004500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.567900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.385760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.003010E-03 |
| Normal-VS-Type2 PRCC |
1.94379999995942E-06 |
| Normal-VS-KIRP CIMP |
1.784440E-02 |
| Normal-VS-Unclassified PRCC |
7.192800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.015600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.108600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.665410E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.244400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.788130E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.487010E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.67789999999868E-06 |
| Normal-vs-N1 |
1.069630E-01 |
| Normal-vs-N2 |
4.547500E-02 |
| N0-vs-N1 |
2.878300E-02 |
| N0-vs-N2 |
9.031400E-01 |
| N1-vs-N2 |
4.202800E-01 |
|
|
